KMT2C deficiency drives transdifferentiation of double-negative prostate cancer and confer resistance to AR-targeted therapy
Author:
Jiacheng Guo,Ni Li,Qiuli Liu,Zongyao Hao,Guanghui Zhu,Xuege Wang,Hanling Wang,Qiang Pan,Beitao Xu,Ying Han,Guoying Zhang,Yannan Lian,Wei Zhang,Yongqiang Gu,Naiheng Lin,Xin Zeng,Zige Jin,Weihua Lan,Jun Jiang,Dong Gao,Liang Dong,Huairui Yuan et al.
© 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.